Silencing of MCT1 with a validated siRNA pool (Supporting information, Supplementary Figure 2C) in the same cell line panel significantly reduced the cell number in only four ccRCC cell lines (Figure 2B, mean reduction 30%). This evidence concerns the gene SLC16A1 and nonpapillary renal cell carcinoma.